By virtue of Israel's entrepreneurial culture and close ties to America, Israeli emerging growth companies have a strong presence in the United States. More Israeli companies are listed on Nasdaq than those of any other country outside North America, second only to Canadian companies.   

Since 1993, the average size of the leading Israeli venture capital’s fund, jumped from $20M in 1993 to more than $250 M today.  Israeli startups have raised more than $5.2 billion in initial public offerings on NASDAQ in the last five years, and is one of the world's largest recipients of venture-capital financing.

An entrepreneurial culture, favorable government programs and incentives, and a very highly educated workforce, are some of the reasons why Israel has become a breeding ground for emerging growth companies, and technology start-ups.

Kahn Kleinman has been in front of the curve – counseling Israeli start-up companies engaged in the development of technological innovation with global application in areas of medical technology, medical instruments, computer software and hardware, IT, and life sciences including medical devices, biotechnology and biosoftware.  Our services to these Israeli companies include:

• Establishing U.S. affiliates
• Counseling companies in regard to all aspects of the capital formation and venture capital process
• Mergers and acquisitions
• Advising on general corporate, governance, litigation, and employment matters
• Formulating and implementing U.S. and international business operations, strategic alliances, and joint ventures.

Our clients benefit from our relationships and experience in the technology and venture capital communities. Similarly, our understanding of Israeli business and the technology market contributes greatly to the business success of our Israeli clients.